BFC Planning’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
BFC Planning's MRNA Position: Q3 2026 in Review
BFC Planning increased its Moderna (MRNA) stake by 628% in Q3 2026, buying an estimated $1.87M and bringing the position to 20,094 shares worth $3.87M. The position accounts for 0.15% of the portfolio, ranked #137.
BFC Planning first reported a position in MRNA in Q3 2024 and has held it in 9 quarters since. The position peaked at $7.64M in Q1 2026. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- BFC Planning held 20,094 shares of Moderna worth $3.87M as of Q3 2026.
- BFC Planning bought 17,332 Moderna shares in Q3 2026, an estimated $1.87M.
- Moderna made up 0.15% of BFC Planning's portfolio in Q3 2026, its #137 holding.
- BFC Planning first reported a position in Moderna in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Moderna position peaked at $7.64M in Q1 2026.
- 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.